Lead party: Y Combinator Management, LLC (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: 54Gene, Inc. (private company) · Sector: Healthcare, Biotechnology · Countries of operation: Nigeria
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Seed · Deal amount: US$4.5m · Fund: KdT Ventures Fund I, LP
Investors/buyers: Y Combinator Management, LLC, Fifty Years Industries, LLC, Better Ventures, KdT Ventures LLC, Hack VC Management, LLC, Techammer
Legal advisers: not identified in the source record.
Source: announced 2 July 2019. Original announcement: techcrunch.com.


